| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
Departments of Medicine, Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois
Requests for reprints: Andrei L. Gartel, Department of Medicine University of Illinois at Chicago, 840 South Wood Street, Room 1041, Chicago, IL 60612. Phone: 312-996-1855; Fax: 312-996-8697; E-mail: agartel{at}uic.edu.
The cyclin-dependent kinase inhibitor p21WAF1/CIP1 is a major player in cell cycle control and it is mainly regulated at the transcriptional level. Whereas induction of p21 predominantly leads to cell cycle arrest, repression of p21 may have a variety of outcomes depending on the context. In this review, we concentrate on transcriptional repression of p21 by cellular and viral factors, and delve in detail into its possible biological implications and its role in cancer. It seems that the major mode of p21 transcriptional repression by negative regulators is the interference with positive transcription factors without direct binding to the p21 promoter. Specifically, the negative factors may either inhibit binding of positive regulators to the promoter or hinder their transcriptional activity. The ability of p21 to inhibit proliferation may contribute to its tumor suppressor function. Because of this, it is not surprising that a number of oncogenes repress p21 to promote cell growth and tumorigenesis. However, p21 is also an inhibitor of apoptosis and p21 repression may also have an anticancer effect. For example, c-Myc and chemical p21 inhibitors, which repress p21, sensitize tumor cells to apoptosis by anticancer drugs. Further identification of factors that repress p21 is likely to contribute to the better understanding of its role in cancer.
This article has been cited by other articles:
|
|
 |
|
  R. M. Tuder, J. H. Yun, and B. B. Graham Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Lim, Y.-S. Chun, and J.-W. Park Hypoxia-Inducible Factor-1{alpha} Obstructs a Wnt Signaling Pathway by Inhibiting the hARD1-Mediated Activation of {beta}-Catenin Cancer Res., July 1, 2008; 68(13): 5177 - 5184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Eun, Y. Lee, S. Hong, J. Kim, H.-W. Lee, K. Kim, W. Sun, and H. Kim Hes6 Controls Cell Proliferation via Interaction with cAMP-response Element-binding Protein-binding Protein in the Promyelocytic Leukemia Nuclear Body J. Biol. Chem., February 29, 2008; 283(9): 5939 - 5949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Pechnick, S. Zonis, K. Wawrowsky, J. Pourmorady, and V. Chesnokova p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus PNAS, January 29, 2008; 105(4): 1358 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Hwang-Verslues and F. M. Sladek Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha}1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter Mol. Endocrinol., January 1, 2008; 22(1): 78 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Kolomeichuk, A. Bene, M. Upreti, R. A. Dennis, C. S. Lyle, M. Rajasekaran, and T. C. Chambers Induction of Apoptosis by Vinblastine via c-Jun Autoamplification and p53-Independent Down-Regulation of p21WAF1/CIP1 Mol. Pharmacol., January 1, 2008; 73(1): 128 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, M. R. Spitz, H. Yang, C. Lu, D. J. Stewart, and X. Wu Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5974 - 5981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Opavsky, S.-Y. Tsai, M. Guimond, A. Arora, J. Opavska, B. Becknell, M. Kaufmann, N. A. Walton, J. A. Stephens, S. A. Fernandez, et al. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis PNAS, September 25, 2007; 104(39): 15400 - 15405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, Z. Wang, and N. S. Magnuson Pim-1 Kinase-Dependent Phosphorylation of p21Cip1/WAF1 Regulates Its Stability and Cellular Localization in H1299 Cells Mol. Cancer Res., September 1, 2007; 5(9): 909 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Mahon, P. Baril, V. Bhakta, C. Chelala, K. Caulee, T. Harada, and N. R. Lemoine S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic Cancer Cancer Res., July 15, 2007; 67(14): 6786 - 6795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kojima, M. Konopleva, I. J. Samudio, V. Ruvolo, and M. Andreeff Mitogen-Activated Protein Kinase Kinase Inhibition Enhances Nuclear Proapoptotic Function of p53 in Acute Myelogenous Leukemia Cells Cancer Res., April 1, 2007; 67(7): 3210 - 3219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Kuhn, S. Roy, J. Radtke, S. Khanna, and C. K. Sen Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1245 - H1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gong, J. Yue, X. Wu, X. Wang, J. Wen, L. Lu, X. Peng, B. Qiang, and J. Yuan NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element Nucleic Acids Res., December 4, 2006; 34(21): 6158 - 6169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sohn, F. Essmann, K. Schulze-Osthoff, and R. U. Janicke p21 Blocks Irradiation-Induced Apoptosis Downstream of Mitochondria by Inhibition of Cyclin-Dependent Kinase-Mediated Caspase-9 Activation Cancer Res., December 1, 2006; 66(23): 11254 - 11262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Xiao, D. Li, H.-Q. Zhu, M.-G. Song, X.-R. Pan, P.-M. Jia, L.-L. Peng, A.-X. Dou, G.-Q. Chen, S.-J. Chen, et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins PNAS, October 31, 2006; 103(44): 16448 - 16453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mologni, E. Sala, S. Cazzaniga, R. Rostagno, T. Kuoni, M. Puttini, J. Bain, L. Cleris, S. Redaelli, B. Riva, et al. Inhibition of RET tyrosine kinase by SU5416. J. Mol. Endocrinol., October 1, 2006; 37(2): 199 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Mak, M.-H. Chen, T. F. Day, P.-T. Chuang, and Y. Yang Wnt/{beta}-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation Development, September 15, 2006; 133(18): 3695 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Hsu, C.-Y. Cho, P.-L. Kuo, Y.-T. Huang, and C.-C. Lin Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 484 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Gartel Is p21 an oncogene? Mol. Cancer Ther., June 1, 2006; 5(6): 1385 - 1386. [Full Text] [PDF]
|
|
|
|
|
|
A. J. Wilson, D.-S. Byun, N. Popova, L. B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L. H. Augenlicht, and J. M. Mariadason Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer J. Biol. Chem., May 12, 2006; 281(19): 13548 - 13558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ouyang, J. L. Williams, G. J. Tsioulias, J. Gao, M. J. Iatropoulos, L. Kopelovich, K. Kashfi, and B. Rigas Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Res., April 15, 2006; 66(8): 4503 - 4511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhao, S. Lu, L. Wu, G. Chai, H. Wang, Y. Chen, J. Sun, Y. Yu, W. Zhou, Q. Zheng, et al. Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1. Mol. Cell. Biol., April 1, 2006; 26(7): 2782 - 2790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Radhakrishnan and A. L. Gartel A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity. Cancer Res., March 15, 2006; 66(6): 3264 - 3270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Nagl Jr., D. R. Zweitzig, B. Thimmapaya, G. R. Beck Jr., and E. Moran The c-myc Gene Is a Direct Target of Mammalian SWI/SNF-Related Complexes during Differentiation-Associated Cell Cycle Arrest Cancer Res., February 1, 2006; 66(3): 1289 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Meletis, V. Wirta, S.-M. Hede, M. Nister, J. Lundeberg, and J. Frisen p53 suppresses the self-renewal of adult neural stem cells Development, January 15, 2006; 133(2): 363 - 369. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
